Literature DB >> 6388149

Studies on reovirus receptors of L cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes.

G D Armstrong, R W Paul, P W Lee.   

Abstract

"Saturation binding experiments" were carried out to characterize the attachment of reovirus to mouse L fibroblasts. Scatchard analysis of data obtained from such experiments suggests that one homogeneous set of noncooperative, high affinity binding sites are involved in reovirus attachment. It is estimated that L cells possess between 3 and 5 X 10(5) reovirus binding sites per cell and that the equilibrium dissociation constant (KD) is approximately 3 X 10(-9) M. Scatchard analysis of data from similar experiments, carried out in the presence of anti-sigma 1 and anti-sigma 3 antibodies, revealed that although both antibodies prevent viral attachment, they exhibit distinct binding inhibition characteristics: anti-sigma 1 effectively abolishes high-affinity, specific binding, whereas anti-sigma 3 apparently blocks low-affinity, nonspecific interactions. The nature of the L-cell receptor was then probed using various enzymes and reagents, and compared with that of the reovirus receptor on human type O erythrocytes. It was found that whereas reovirus hemagglutination (HA) is inhibited by pretreatment of erythrocytes with various proteases or neuraminidase, virus binding to L cells is unaffected by such treatments. Neither HA nor cell binding is inhibited by the various sugars tested, including N-acetyl-D-glucosamine, which was previously reported to inhibit reovirus HA (L. D. Gelb and A. M. Lerner, 1965, Science 147, 404-405). Both L cells and erythrocyte reovirus receptors are nevertheless highly sensitive to periodate treatment, which presumably destroys the high-affinity reovirus binding sites since protein sigma 1, which is capable of attaching to L cells by itself, does not bind to cells pretreated with periodate. It is therefore concluded that sugar residues on the receptor may be involved in this specific interaction. The possibility that gangliosides may serve as reovirus receptors was also probed. It was found that bovine brain gangliosides, but not cerebrosides, readily aggregate reovirus, inhibit HA, and block viral attachment to L cells. However, binding of protein sigma 1 to L cells is unaffected by gangliosides. Inhibition of reovirus HA and L-cell binding by these gangliosides is therefore most likely due to a steric hindrance effect brought about by interactions between the gangliosides and other components of the outer viral capsid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388149     DOI: 10.1016/0042-6822(84)90145-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

1.  Complete in vitro assembly of the reovirus outer capsid produces highly infectious particles suitable for genetic studies of the receptor-binding protein.

Authors:  K Chandran; X Zhang; N H Olson; S B Walker; J D Chappell; T S Dermody; T S Baker; M L Nibert
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells.

Authors:  D H Rubin; J D Wetzel; W V Williams; J A Cohen; C Dworkin; T S Dermody
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 3.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

4.  JAM-A-independent, antibody-mediated uptake of reovirus into cells leads to apoptosis.

Authors:  Pranav Danthi; Mark W Hansberger; Jacquelyn A Campbell; J Craig Forrest; Terence S Dermody
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Persistent reovirus infections of L cells select mutations in viral attachment protein sigma1 that alter oligomer stability.

Authors:  G J Wilson; J D Wetzel; W Puryear; R Bassel-Duby; T S Dermody
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1.

Authors:  J D Chappell; V L Gunn; J D Wetzel; G S Baer; T S Dermody
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Endothelial JAM-A promotes reovirus viremia and bloodstream dissemination.

Authors:  Caroline M Lai; Karl W Boehme; Andrea J Pruijssers; Vrajesh V Parekh; Luc Van Kaer; Charles A Parkos; Terence S Dermody
Journal:  J Infect Dis       Date:  2014-08-22       Impact factor: 5.226

8.  A monoclonal antibody specific for reovirus outer-capsid protein sigma3 inhibits sigma1-mediated hemagglutination by steric hindrance.

Authors:  E L Nason; J D Wetzel; S K Mukherjee; E S Barton; B V Prasad; T S Dermody
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells.

Authors:  J R Gentsch; A F Pacitti
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

10.  Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines.

Authors:  M Herrmann; M Oppenländer; M Pawlita
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.